文献速递中医内科中药与中成药合理使用

中药复方治疗阴虚型失眠临床研究的可视化分析与评价

Visual analysis and evaluation of clinical research on Traditional Chinese medicine compounds in treating insomnia of Yin deficiency syndrome.
PubMed 文献 · J Ethnopharmacol · 2022-08-27

该研究系统挖掘中药复方治疗阴虚型失眠(IYDS)的临床研究数据,纳入184项相关研究,采用文献计量学、VOSviewer可视化、关联规则分析及Cochrane工具与MINORS量表进行质量评价。结果显示研究热度呈动态上升趋势,常用药物为酸枣仁等,常用方剂为黄连阿胶汤等,但研究设计规范性不足,含伦理批件和明确纳入标准的研究不足50%。

要点

  • 中药复方治疗阴虚型失眠研究热度上升,常用酸枣仁、黄连阿胶汤等。
  • 该领域研究设计规范性不足,伦理批件与纳入标准报告率未达50%。
  • 疗效关键指标经Meta分析与敏感性分析证实有效且稳定。

核心结论

  • 中药复方治疗阴虚型失眠的临床研究数量呈动态上升趋势,结局指标趋于多样化和细化。
  • 该领域临床研究设计不够规范,但关键疗效指标科学且稳定。

研究设计与样本

  • 研究采用循证医学策略与EndNote检索管理文献,用文献计量学挖掘数据特征。
  • 使用VOSviewer制作可视化知识图谱,IBM SPSS Modeler进行中药关联规则分析。
  • 采用Cochrane工具和MINORS量表对文献进行质量分析。
  • 共纳入184项相关研究。

主要发现

  • 研究热度呈动态上升趋势,研究热点呈现迁移和细化趋势。
  • 常用中药为酸枣仁等,常用方剂为黄连阿胶汤等,常用剂型为传统汤剂等。
  • 常用药对包括酸枣仁-茯苓等。
  • 含伦理审查编号和明确纳入标准的研究比例未达50%,方法学偏倚风险高。
  • 近年研究设计规范性明显上升,Meta分析和敏感性分析可证实临床疗效的有效性和稳定性。

关键数值与推荐

  • 含伦理审查编号和明确纳入标准的研究比例未达50%。
  • 同名中药复方不同临床研究的给药方案存在显著差异。
  • 常用剂型以汤剂为主,中成药为辅。

临床怎么用

  • 临床可参考常用药物酸枣仁、常用方剂黄连阿胶汤及药对酸枣仁-茯苓治疗阴虚型失眠。
  • 剂型选择以传统汤剂为主,可辅以中成药。
  • 应用同名复方时需注意不同研究给药方案存在显著差异。

局限性

  • 该领域临床研究设计不够规范,方法学偏倚风险高。
  • 含伦理审查编号和明确纳入标准的研究比例未达50%。
  • 同名中药复方给药方案的独特科学意义有待阐述或讨论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Insomnia is a common form of sleep disorder. Traditional Chinese medicine (TCM) compounds have definite curative effects and a low incidence of adverse reactions, which is recognized to be an effective intervention means for the treatment of insomnia. AIM OF THE STUDY: Based on mining the clinical research data of treating insomnia of yin deficiency syndrome (IYDS) with TCM compounds systematically, the study is to analyze the research hotspots and development trends in this field, explore the medication rule, evaluate the quality of research, so as to provide reference and direction for clinical application and scientific research in this field. MATERIALS AND METHODS: The relevant literature was retrieved and managed by evidence-based medicine strategy and EndNote software respectively. The bibliometric method was used to mine and analyze data characteristics. The VOSviewer software was used to make visual knowledge maps, the IBM SPSS Modeler software was used for association rule analysis of herbs, and the Cochrane tool and MINORS scale were used for quality analysis of literature. RESULTS: (1) A total of 184 related studies were included according to the inclusion and exclusion criteria. (2) The research popularity showed a dynamic upward trend and the research hotspot showed a trend of migration and refinement, etc. (3) The commonly used herbs in this field were Ziziphus jujuba var. spinosa (Bunge) Hu ex H.F.Chow, etc; the commonly used TCM prescriptions were Huanglian Ejiao Decoction, etc; the commonly used dosage forms were traditional decoction, etc; the commonly used combinations of herbs included Ziziphus jujuba var. spinosa (Bunge) Hu ex H.F.Chow-Poria cocos(Schw.)Wolf, etc. (4) The rate of the studies containing ethical review numbers and clear inclusion standards did not reach 50%, and the risk bias of methodological was high. However, a separate analysis of data showed that the specification of study design was on the rise obviously in recent years, and Meta-analysis and sensitivity analysis could confirm the effectiveness and stability of clinical efficacy which was the key indicator in treating IYDS with TCM prescriptions. There were significant differences among administration protocols of different clinical studies of the same name TCM compounds. However, the scientific significance of each unique dosing regimen were expected to be elaborated or discussed. CONCLUSION: The clinical research number of TCM compounds treating IYDS was in a dynamic upward trend, and the outcome indicators tended to be diversified and detailed. The dosage forms mainly included decoction, supplemented by Chinese patent medicine. The design of clinical studies in this field was not standardized enough, but the key indicators were scientific and stable. We expected that later studies could pay more attention to improving the standardization of trial design, reducing the risk bias in the process of methodological design, conducting high-quality standardized multicenter, large-sample randomized controlled clinical trials to provide scientific evidence with high evidentiary strength, establishing the recognized administration protocols for the same name TCM prescriptions or clarifying the targeting of different protocols, and promoting the application and popularity of TCM compounds in treating IYDS.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Wu Q, Chen X, Gan G, et al. Visual analysis and evaluation of clinical research on Traditional Chinese medicine compounds in treating insomnia of Yin deficiency syndrome. J Ethnopharmacol. 2022. PMID: 36031101. doi:10.1016/j.jep.2022.115669

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。